Herniated Nucleus Pulposus
11
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
1 terminated out of 11 trials
83.3%
-3.3% vs benchmark
9%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (11)
The Course of Hip Flexion Weakness Following LLIF or ALIF
10% Dextrose Versus Triamcinolone Injections After Pulsed Radiofrequency for Herniated Nucleus Pulposus
Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy 3
ViBone in Cervical and Lumbar Spine Fusion
Effectiveness of Conventional Therapy Plus Pulsed-Radiofrequency for Herniated Nucleus Pulposus
RHINE™ Cervical Disc Clinical Study: A Prospective Observational Study for Patients Requiring 1-2 Level C-spine Surgery
Learning Curve, Outcome Parameters, and MRI Assessment of Disc Evacuation After Transforaminal Percutaneous Endoscopic Lumbar Discectomy
The Efficacy of Continuous Cold-Therapy on Postoperative Pain and Narcotics Use Following Spinal Fusion
Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion
Retest-reliability and At-home-assessment Feasibility of the 5R-STS
A Clinical Comparison in Cervical Epidural Pressure Changes Between Midline and Paramedian Approaches